<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-65134" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Determining the Need for Blood Transfusion</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zomorrodi</surname>
            <given-names>Ashkahn</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Picciola</surname>
            <given-names>Elizabeth A.</given-names>
          </name>
          <aff>Louisiana State University Health-Shreveport, Shreveport, LA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hotwagner</surname>
            <given-names>David T.</given-names>
          </name>
          <aff>St Lucie Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ashkahn Zomorrodi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Elizabeth Picciola declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>David Hotwagner declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-65134.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Blood transfusion begins with collecting&#x000a0;whole blood from a donor using a preservative-anticoagulant combination (typically citrate phosphate dextrose or citrate phosphate dextrose adenine-1). The blood is then tested for transfusion-transmitted diseases, separated into its specific components, and then transfused as clinically indicated. This process&#x000a0;is known to have both risks and benefits to the patient, and the decision to transfuse must be based on many variables so that the benefits outweigh the risk.</p>
        <p>Subsequently, the process of patient blood management (PBM) was developed to incorporate an evidence-based, interprofessional approach to blood product administration. This process considers the patient's entire (projected) course and aids the clinician in determining if transfusion is indicated versus the use of alternative care pathways to ensure the best possible outcome for the patient.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-65134.s2" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Red Blood Cells</bold>
</p>
        <p>The literature strongly supports adhering to a restrictive transfusion strategy (7 g/dL) in hospitalized adult and pediatric intensive care patients who are hemodynamically stable.<xref ref-type="bibr" rid="article-65134.r1">[1]</xref><xref ref-type="bibr" rid="article-65134.r2">[2]</xref> The evidence is not as compelling for patients with cardiovascular disease, but recommendations are to adhere to a restrictive strategy (hemoglobin 8 gm/dL) for patients with preexisting cardiovascular disease. There is insufficient evidence to make recommendations for patients with acute coronary syndrome.</p>
        <p>RBC transfusion is indicated in actively bleeding patients. The amount should be based on clinical assessment<xref ref-type="bibr" rid="article-65134.r3">[3]</xref> and, if possible, by laboratory tests to guide targeted therapy. However, in patients with upper gastrointestinal bleeding, patients with a restrictive transfusion strategy may have better outcomes.<xref ref-type="bibr" rid="article-65134.r4">[4]</xref></p>
        <p>
<bold>Plasma</bold>
</p>
        <p>There is minimal guidance for plasma transfusion. However, plasma is a frequently prescribed intervention, often for mild to moderate elevations in prothrombin time or an international normalized ratio (INR). This continues to occur despite numerous studies that failed to show a relationship between these elevations and the risk of bleeding or that INR has any ability to predict bleeding.<xref ref-type="bibr" rid="article-65134.r5">[5]</xref></p>
        <p>The Cochrane Reviews found no evidence to support plasma transfusions in patients who were not coagulopathic undergoing elective cardiac surgery or critically ill patients.</p>
        <p>The British Society of Haematology (BSH) published recommendations in 2018 for various patient groups in the absence of major bleeding.<xref ref-type="bibr" rid="article-65134.r6">[6]</xref><xref ref-type="bibr" rid="article-65134.r7">[7]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>There is no evidence to support the prophylactic use of plasma in non-bleeding patients with abnormal standard coagulation tests pre-procedure</p>
          </list-item>
          <list-item>
            <p>The impact of commonly used doses to correct clotting results or to reduce the bleeding risk is very limited, especially when the PT ratio or INR is between 1.5&#x000a0;to 1.9.</p>
          </list-item>
          <list-item>
            <p>Vitamin K should be administered in patients with prolonged PT that is likely to be due to acquired vitamin K deficiency.</p>
          </list-item>
        </list>
        <p>In patients with liver disease, plasma is often transfused to correct a prolonged INR. British Society of Haematology recommends these guidelines:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>PT and APTT do not reflect the true hemostatic status of patients with advanced liver disease.</p>
          </list-item>
          <list-item>
            <p>There is no good evidence to endorse the use of prophylactic plasma for the correction of abnormal clotting tests in non-bleeding patients prior to interventions such as elective variceal bleeding.</p>
          </list-item>
          <list-item>
            <p>There is no good evidence to support a role for prophylactic plasma to reduce the risk of bleeding from a percutaneous liver biopsy.</p>
          </list-item>
          <list-item>
            <p>Prophylactic transfusion of plasma should not be given in low bleeding risk procedures.</p>
          </list-item>
          <list-item>
            <p>Do not use plasma for volume replacement.</p>
          </list-item>
        </list>
        <p>And for sites that have 4-Factor prothrombin concentrates, this should always be the first therapeutic of choice to reverse warfarin emergently.</p>
        <p>
<bold>Cryoprecipitate</bold>
</p>
        <p>There are little data on the use of cryoprecipitate in non-bleeding patients, and it is often used prophylactically but not based on good quality evidence.</p>
        <p>The British Society of Haematology<xref ref-type="bibr" rid="article-65134.r8">[8]</xref> recommends:</p>
        <list list-type="bullet">
          <list-item>
            <p>There is insufficient evidence on which to base a recommendation about the threshold of fibrinogen to transfuse cryoprecipitate, or the optimal dose, in patients with hypofibrinogenemia undergoing procedures.</p>
          </list-item>
          <list-item>
            <p>If fibrinogen is &#x0003c;1.0g/L (100 mg/dL) and other factors (i.e., personal/family bleeding history, drug history, bleeding risk associated with planned procedure) indicate a significant bleeding risk before a procedure, a starting dose of two five donor pools of cryoprecipitate [10 individual units] can be considered (but there is no evidence to support this).</p>
          </list-item>
        </list>
        <p>Many US sites consider fibrinogen &#x0003c;2.0 g/L (&#x0003c;200 mg/dL) in a bleeding obstetric patient as an indication to transfuse cryoprecipitate.</p>
        <p>
<bold>Platelets</bold>
</p>
        <p>Common guidelines for platelet transfusions include:<xref ref-type="bibr" rid="article-65134.r9">[9]</xref></p>
        <list list-type="order">
          <list-item>
            <p>Prophylaxis against bleeding&#x02014;PLT count &#x0003c;10,000&#x000a0;per microliter</p>
          </list-item>
          <list-item>
            <p>Neonate&#x02014;PLT count &#x0003c;50,000 per microliter</p>
          </list-item>
          <list-item>
            <p>Bedside procedure&#x02014;PLT count &#x0003c;50,000 per microliter</p>
          </list-item>
          <list-item>
            <p>Kidney or liver biopsy&#x02014;PLT count &#x0003c;50,000 per microliter</p>
          </list-item>
          <list-item>
            <p>Bronchoscopy without biopsy&#x02014;PLT count &#x0003c;50,000 per microliter</p>
          </list-item>
          <list-item>
            <p>Bronchoscopy with biopsy&#x02014;PLT count &#x0003c;75,000 per microliter</p>
          </list-item>
          <list-item>
            <p>Intra-/postoperative bleeding&#x02014;PLT count &#x0003c;50,000 per microliter</p>
          </list-item>
          <list-item>
            <p>Clinical bleeding with dysfunctional PLTs:</p>
          </list-item>
        </list>
        <p>PLT count &#x0003c;50,000 per microliter (medical)</p>
        <p>PLT count &#x0003c;100,000 per microliter (surgical)</p>
        <list list-type="order">
          <list-item>
            <p>Neurosurgery&#x02014;PLT count &#x0003c;100,000 per microliter</p>
          </list-item>
        </list>
        <p>
<bold>Cell Salvage</bold>
</p>
        <p>The Association of Anaesthetists guidelines make the following transfusion recommendations: Use cell salvage when it can be expected to reduce the likelihood of allogeneic (donor) red cell transfusion and/or severe postoperative anemia. Collection of blood for potential cell salvage (&#x02018;collect only&#x02019; mode) should be considered for surgical procedures where blood loss may exceed 500 ml (or &#x0003e; 10% of calculated total blood volume) in adult patients or &#x0003e; 8 mL/kg (&#x0003e; 10% of calculated total blood volume) in children weighing &#x0003e; 10 kg.<xref ref-type="bibr" rid="article-65134.r10">[10]</xref></p>
        <p>
<bold>Whole Blood</bold>
</p>
        <p>There has been increasing interest in using low titer group O whole blood (LTOWB) in military and civilian trauma, and there is evidence to show that it saves lives. <xref ref-type="bibr" rid="article-65134.r11">[11]</xref><xref ref-type="bibr" rid="article-65134.r12">[12]</xref>&#x000a0;It has also been used in non-trauma massive hemorrhage cases. LTOWB provides all of the components of blood (RBCs, platelets, and plasma with fibrinogen) and provides a balanced resuscitation addressing oxygen needs and coagulopathy in a single bag of blood. The whole blood has a critical titer of anti-A and anti-B of less than 50 to 200). The transfusion of up to 4 units of whole blood has been shown to be safe.<xref ref-type="bibr" rid="article-65134.r13">[13]</xref></p>
      </sec>
      <sec id="article-65134.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Single studies may have misleading results. Using the Cochrane database of systematic reviews and meta-analyses, which summarize and interpret the results of medical research, helps minimize the biases of single studies.</p>
      </sec>
      <sec id="article-65134.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Adverse events related to transfusion have been well documented. Transfusion-associated&#x000a0;circulatory overload (TACO), transfusion-related&#x000a0;acute lung injury (TRALI), bacterial contamination, transfusion-associated&#x000a0;dyspnea (TAD), allergic mild to severe, hemolytic, febrile, immunosuppression which can lead to increased risk of infection, increased length of stay. These adverse events are dose-dependent. When restrictive strategies have the support of data, it is reasonable to abide by the recommendations.</p>
      </sec>
      <sec id="article-65134.s5" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>To decrease known morbidity and mortality risks, transfusion guidelines based on evidence-based data have been developed. Results demonstrate that these guidelines can lead to fewer transfusions, better patient outcomes, and, concomitantly, cost reductions for hospitals. Guidelines&#x000a0;alone cannot ensure these benefits, as they must be accompanied by physician education and clinical consideration. Additionally, many transfusion strategies recommend the transfusion of one unit and checking lab values to assess effectiveness. This minimizes the risk of over-transfusion as well as circulatory overload.</p>
      </sec>
      <sec id="article-65134.s6" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Nurses are critical partners in transfusions. They ensure the blood is the right product at the right time for the right reason and, of course, for the right patient. Without these safeguards, patients are at significantly higher risk of a clinically significant adverse event.</p>
      </sec>
      <sec id="article-65134.s7" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>Nurses must monitor transfusions before, during, and after transfusion to ensure an adverse event is recognized early and the transfusion is stopped.&#x000a0;</p>
      </sec>
      <sec id="article-65134.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=65134&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=65134">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/65134/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=65134">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-65134.s9">
        <title>References</title>
        <ref id="article-65134.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Kleinman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tinmouth</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Marques</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Fung</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Holcomb</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Illoh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Roback</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Shander</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tobian</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Swinton McLaughlin</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Djulbegovic</surname>
                <given-names>B</given-names>
              </name>
              <collab>Clinical Transfusion Medicine Committee of the AABB</collab>
            </person-group>
            <article-title>Red blood cell transfusion: a clinical practice guideline from the AABB*.</article-title>
            <source>Ann Intern Med</source>
            <year>2012</year>
            <month>Jul</month>
            <day>03</day>
            <volume>157</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-58</page-range>
            <pub-id pub-id-type="pmid">22751760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Heddle</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Fung</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Gernsheimer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Holcomb</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Roback</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Shander</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tobian</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Nov</month>
            <day>15</day>
            <volume>316</volume>
            <issue>19</issue>
            <fpage>2025</fpage>
            <page-range>2025-2035</page-range>
            <pub-id pub-id-type="pmid">27732721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szczepiorkowski</surname>
                <given-names>ZM</given-names>
              </name>
              <name>
                <surname>Dunbar</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Transfusion guidelines: when to transfuse.</article-title>
            <source>Hematology Am Soc Hematol Educ Program</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>638</fpage>
            <page-range>638-44</page-range>
            <pub-id pub-id-type="pmid">24319244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villanueva</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Colomo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Concepci&#x000f3;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hernandez-Gea</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aracil</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Graupera</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Poca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alvarez-Urturi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gordillo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guarner-Argente</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Santal&#x000f3;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;iz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guarner</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Transfusion strategies for acute upper gastrointestinal bleeding.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Jan</month>
            <day>03</day>
            <volume>368</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-21</page-range>
            <pub-id pub-id-type="pmid">23281973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roback</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Caldwell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davenport</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Drew</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Eder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fung</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Luban</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Perkins</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Sachais</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Shander</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tormey</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Waters</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Djulbegovic</surname>
                <given-names>B</given-names>
              </name>
              <collab>American Association for the Study of Liver</collab>
              <collab>American Academy of Pediatrics</collab>
              <collab>United States Army</collab>
              <collab>American Society of Anesthesiology</collab>
              <collab>American Society of Hematology</collab>
            </person-group>
            <article-title>Evidence-based practice guidelines for plasma transfusion.</article-title>
            <source>Transfusion</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>1227</fpage>
            <page-range>1227-39</page-range>
            <pub-id pub-id-type="pmid">20345562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karam</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tucci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Combescure</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lacroix</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rimensberger</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Plasma transfusion strategies for critically ill patients.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2013</year>
            <month>Dec</month>
            <day>28</day>
            <issue>12</issue>
            <fpage>CD010654</fpage>
            <pub-id pub-id-type="pmid">24374651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desborough</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sandu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brunskill</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Doree</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trivella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Montedori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abraha</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Stanworth</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Fresh frozen plasma for cardiovascular surgery.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Jul</month>
            <day>14</day>
            <volume>2015</volume>
            <issue>7</issue>
            <fpage>CD007614</fpage>
            <pub-id pub-id-type="pmid">26171897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Green</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bolton-Maggs</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Beattie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cardigan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kallis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Stanworth</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Thachil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zahra</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding.</article-title>
            <source>Br J Haematol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>181</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-67</page-range>
            <pub-id pub-id-type="pmid">29527654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarode</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Refaai</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Matevosyan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Burner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hampton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rutherford</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction.</article-title>
            <source>Transfusion</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>487</fpage>
            <page-range>487-92</page-range>
            <pub-id pub-id-type="pmid">19804569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klein</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Charlton</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guckian-Fisher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McCrossan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nimmo</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shreeve</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Torella</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Association of Anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018.</article-title>
            <source>Anaesthesia</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>73</volume>
            <issue>9</issue>
            <fpage>1141</fpage>
            <page-range>1141-1150</page-range>
            <pub-id pub-id-type="pmid">29989144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shackelford</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Del Junco</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Powell-Dunford</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mazuchowski</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Kotwal</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Gurney</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stockinger</surname>
                <given-names>ZT</given-names>
              </name>
            </person-group>
            <article-title>Association of Prehospital Blood Product Transfusion During Medical Evacuation of Combat Casualties in Afghanistan With Acute and 30-Day Survival.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Oct</month>
            <day>24</day>
            <volume>318</volume>
            <issue>16</issue>
            <fpage>1581</fpage>
            <page-range>1581-1591</page-range>
            <pub-id pub-id-type="pmid">29067429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>O&#x002bc;Keeffe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inaba</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bulger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Holcomb</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Cotton</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Every minute counts: Time to delivery of initial massive transfusion cooler and its impact on mortality.</article-title>
            <source>J Trauma Acute Care Surg</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-24</page-range>
            <pub-id pub-id-type="pmid">28452870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65134.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seheult</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Anto</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Alarcon</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Sperry</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Triulzi</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Yazer</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Clinical outcomes among low-titer group O whole blood recipients compared to recipients of conventional components in civilian trauma resuscitation.</article-title>
            <source>Transfusion</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>58</volume>
            <issue>8</issue>
            <fpage>1838</fpage>
            <page-range>1838-1845</page-range>
            <pub-id pub-id-type="pmid">30160310</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
